ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Two Loading Regimens of Sunitinib Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01309633
Recruitment Status : Recruiting
First Posted : March 7, 2011
Last Update Posted : June 22, 2016
Sponsor:
Information provided by (Responsible Party):
National University Hospital, Singapore

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2017
  Estimated Study Completion Date : September 2018